Auger electrons for cancer therapy – a review

by Anthony Ku, Valerie J. Facca, Zhongli Cai, Raymond M. Reilly
Published 2019-10-01

Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, 111In or β-particle emitting, 177Lu

by Sadaf Aghevlian, Zhongli Cai, David Hedley, Mitchell A. Winnik, Raymond M. Reilly
Published 2020-11-01

Estrone-3-sulphate, a potential novel ligand for targeting breast cancers.

by Nilasha Banerjee, Humphrey Fonge, Andrew Mikhail, Raymond M Reilly, Reina Bendayan, Christine Allen
Published 2013-01-01

A radiolabeled antibody targeting CD123+ leukemia stem cells – initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML

by Jeffrey V. Leyton, Catherine Gao, Brent Williams, Armand Keating, Mark Minden, Raymond M. Reilly
Published 2015-01-01

Dose predictions for [177Lu]Lu-DOTA-panitumumab F(ab′)2 in NRG mice with HNSCC patient-derived tumour xenografts based on [64Cu]Cu-DOTA-panitumumab F(ab′)2 – implications for a PET...

by Anthony Ku, Misaki Kondo, Zhongli Cai, Jalna Meens, Min Rong Li, Laurie Ailles, Raymond M. Reilly
Published 2021-08-01

Development of an epidermal growth factor derivative with EGFR blocking activity.

by Clara Panosa, Francesc Tebar, Montserrat Ferrer-Batallé, Humphrey Fonge, Masaharu Seno, Raymond M Reilly, Anna Massaguer, Rafael De Llorens
Published 2013-01-01